This year again, Valbiotis is happy to participate in the Biotech and Healthcare seminar organized by Portzamparc, on October 4 and 5 to discuss with the investors community on the latest advances and the Company's new strategic perspectives. The opportunity for Sébastien PELTIER and Frédéric PELONG, CEO and CFO of Valbiotis, to review the remarkable results of the REVERSE-IT study with TOTUM•63, in partnership with Nestlé Health Science and to discuss the high commercial ambitions of Valbiotis , at the dawn of the first launches on the market.